Equillium
22 hedge funds and large institutions have $14.1M invested in Equillium in 2019 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 4 closing their positions.
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
5% more funds holding
Funds holding: 21 → 22 (+1)
0.71% less ownership
Funds ownership: 24.73% → 24.02% (-0.71%)
14% less capital invested
Capital invested by funds: $16.3M → $14.1M (-$2.22M)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$2.21M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
+$619K |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
+$569K |
| 4 |
Renaissance Technologies
New York
|
+$94.2K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
+$52.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$4.05M |
| 2 |
Millennium Management
New York
|
-$81.1K |
| 3 |
PIM
Partner Investment Management
San Francisco,
California
|
-$20K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$6.88K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$2.35K |
EQ Hedge Fund Activity: Q4 2019 in Review
22 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Equillium (EQ) for Q4 2019, worth a combined $14.1M — down 14% from $16.3M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new EQ positions and 4 closed out — a net gain of 1 holder — while 5 added to existing stakes and 6 trimmed.
The largest buyer was Goldman Sachs, opening a new position worth an estimated $2.21M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $4.05M sold.
- 22 institutional investors held Equillium (EQ) as of Q4 2019, up from 21 in Q3 2019.
- Funds reported $14.1M of Equillium stock for Q4 2019, down 14% quarter-over-quarter.
- 5 funds opened new Equillium positions in Q4 2019 and 4 closed out, a net change of +1 holder.
- The largest Equillium buyer in Q4 2019 was Goldman Sachs, an estimated $2.21M added.
- The largest Equillium seller in Q4 2019 was PFM Health Sciences, an estimated $4.05M sold.
Based on aggregated 13F filings for Q4 2019.